• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射频消融治疗肝细胞癌后亚段内复发的频率、危险因素与生存。

Frequency, risk factors and survival associated with an intrasubsegmental recurrence after radiofrequency ablation for hepatocellular carcinoma.

机构信息

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

出版信息

PLoS One. 2013 Apr 12;8(4):e59040. doi: 10.1371/journal.pone.0059040. Print 2013.

DOI:10.1371/journal.pone.0059040
PMID:23593129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3625228/
Abstract

BACKGROUND

In the treatment of hepatocellular carcinoma (HCC), hepatic resection has the advantage over radiofrequency ablation (RFA) in terms of systematic removal of a hepatic segment.

METHODS

We enrolled 303 consecutive patients of a single naïve HCC that had been treated by RFA at The University of Tokyo Hospital from 1999 to 2004. Recurrence was categorized as either intra- or extra-subsegmental as according to the Couinaud's segment of the original nodule. To assess the relationship between the subsegments of the original and recurrent nodules, we calculated the kappa coefficient. We assessed the risk factors for intra- and extra-subsegmental recurrence independently using univariate and multivariate Cox proportional hazard regression. We also assessed the impact of the mode of recurrence on the survival outcome.

RESULTS

During the follow-up period, 201 patients in our cohort showed tumor recurrence distributed in a total of 340 subsegments. Recurrence was categorized as exclusively intra-subsegmental, exclusively extra-subsegmental, and simultaneously intra- and extra-subsegmental in 40 (20%), 110 (55%), and 51 (25%) patients, respectively. The kappa coefficient was measured at 0.135 (95% CI, 0.079-0.190; P<0.001). Multivariate analysis revealed that of the tumor size, AFP value and platelet count were all risk factors for both intra- and extra-subsegmental recurrence. Of the patients in whom recurrent HCC was found to be exclusively intra-subsegmental, extra-subsegmental, and simultaneously intra- and extra-subsegmental, 37 (92.5%), 99 (90.8%) and 42 (82.3%), respectively, were treated using RFA. The survival outcomes after recurrence were similar between patients with an exclusively intra- or extra-subsegmental recurrence.

CONCLUSIONS

The effectiveness of systematic subsegmentectomy may be limited in the patients with both HCC and chronic liver disease who frequently undergo multi-focal tumor recurrence.

摘要

背景

在肝细胞癌(HCC)的治疗中,肝切除术相对于射频消融(RFA)具有系统性切除肝段的优势。

方法

我们纳入了 1999 年至 2004 年在东京大学医院接受 RFA 治疗的 303 例初治单灶 HCC 患者。根据原始结节的 Couinaud 节段,复发分为节内或节外。为了评估原始和复发性结节的亚段之间的关系,我们计算了 Kappa 系数。我们使用单因素和多因素 Cox 比例风险回归分别独立评估节内和节外复发的危险因素。我们还评估了复发模式对生存结果的影响。

结果

在随访期间,我们队列中的 201 例患者显示肿瘤复发分布在总共 340 个亚段中。复发分为单纯节内、单纯节外和同时节内和节外,分别为 40 例(20%)、110 例(55%)和 51 例(25%)。Kappa 系数为 0.135(95%CI,0.079-0.190;P<0.001)。多因素分析显示,肿瘤大小、AFP 值和血小板计数均是节内和节外复发的危险因素。在复发性 HCC 被发现为单纯节内、单纯节外和同时节内和节外的患者中,分别有 37(92.5%)、99(90.8%)和 42(82.3%)例患者接受了 RFA 治疗。复发后,仅节内或节外复发患者的生存结果相似。

结论

在患有 HCC 和慢性肝病的患者中,系统的亚段切除术的效果可能有限,这些患者经常发生多灶性肿瘤复发。

相似文献

1
Frequency, risk factors and survival associated with an intrasubsegmental recurrence after radiofrequency ablation for hepatocellular carcinoma.射频消融治疗肝细胞癌后亚段内复发的频率、危险因素与生存。
PLoS One. 2013 Apr 12;8(4):e59040. doi: 10.1371/journal.pone.0059040. Print 2013.
2
Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.肝细胞癌射频消融术后的无复发生存率。风险因素对结局影响的登记报告。
Jpn J Clin Oncol. 2007 Sep;37(9):658-72. doi: 10.1093/jjco/hym086. Epub 2007 Aug 31.
3
Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C.丙型肝炎患者肝细胞癌射频消融术后肝细胞癌复发的危险因素
World J Gastroenterol. 2005 Apr 14;11(14):2174-8. doi: 10.3748/wjg.v11.i14.2174.
4
Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.单次经皮射频消融术后肝细胞癌局部复发的危险因素
J Gastroenterol. 2003;38(10):977-81. doi: 10.1007/s00535-003-1181-0.
5
Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.射频消融与再次切除治疗初始根治性切除后复发的≤5cm 肝细胞癌。
Eur Radiol. 2020 Nov;30(11):6357-6368. doi: 10.1007/s00330-020-06990-8. Epub 2020 Jun 11.
6
Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy.高血糖是根治性治疗后肝细胞癌的一个重要预后因素。
World J Gastroenterol. 2013 Jan 14;19(2):249-57. doi: 10.3748/wjg.v19.i2.249.
7
Local recurrence and complications after percutaneous radiofrequency ablation of hepatocellular carcinoma: a retrospective cohort study focused on tumor location.肝细胞癌经皮射频消融术后的局部复发及并发症:一项聚焦肿瘤位置的回顾性队列研究
Acta Med Okayama. 2015;69(4):219-26. doi: 10.18926/AMO/53558.
8
Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.消融后去γ-羧基凝血酶原水平可预测乙型肝炎相关肝细胞癌的预后。
Liver Int. 2016 Apr;36(4):580-7. doi: 10.1111/liv.12991. Epub 2015 Nov 18.
9
Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.经皮射频消融作为小肝癌的一线治疗:长期随访结果和预后因素。
J Gastroenterol Hepatol. 2010 Mar;25(3):597-604. doi: 10.1111/j.1440-1746.2009.06125.x. Epub 2010 Jan 14.
10
Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.对比增强超声检查显示的不规则血管模式以及高血清豆凝集素反应性甲胎蛋白水平预示着早期肝细胞癌患者射频消融成功后预后不良。
Cancer Med. 2016 Nov;5(11):3111-3120. doi: 10.1002/cam4.932. Epub 2016 Oct 17.

引用本文的文献

1
Retreatment with immunotherapy in a patient with hepatocellular carcinoma who received immune checkpoint inhibitors after primary curative treatment: a case report.一名肝细胞癌患者在接受初次根治性治疗后接受免疫检查点抑制剂治疗,之后进行免疫治疗再治疗:病例报告
Front Oncol. 2024 Apr 5;14:1321195. doi: 10.3389/fonc.2024.1321195. eCollection 2024.
2
No-Touch Radiofrequency Ablation for Early Hepatocellular Carcinoma: 2023 Korean Society of Image-Guided Tumor Ablation Guidelines.无接触射频消融治疗早期肝细胞癌:2023 年韩国影像引导肿瘤消融治疗指南。
Korean J Radiol. 2023 Aug;24(8):719-728. doi: 10.3348/kjr.2023.0423.
3
Experimental Study of the Ablation Area of Bovine Liver Using STARmed Radiofrequency Ablation.

本文引用的文献

1
Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.肝细胞癌的射频消融:235例西方肝硬化患者的长期结果及预后因素
Hepatology. 2009 Nov;50(5):1475-83. doi: 10.1002/hep.23181.
2
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.预测米兰标准以外的肝细胞癌患者肝移植后的生存率:一项回顾性探索性分析。
Lancet Oncol. 2009 Jan;10(1):35-43. doi: 10.1016/S1470-2045(08)70284-5. Epub 2008 Dec 4.
3
Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study.
采用 STARmed 射频消融的牛肝消融面积的实验研究。
In Vivo. 2023 May-Jun;37(3):1047-1051. doi: 10.21873/invivo.13179.
4
Percutaneous US-guided MWA of small liver HCC: predictors of outcome and risk factors for complications from a single center experience.经皮超声引导下小肝癌微波消融治疗:单中心经验的疗效预测因素和并发症风险因素。
Med Oncol. 2020 Apr 2;37(5):39. doi: 10.1007/s12032-020-01365-x.
5
Resection versus ablation for hepatocellular carcinoma: role of initial treatment.肝细胞癌的切除与消融:初始治疗的作用
Hepat Oncol. 2015 Apr;2(2):101-103. doi: 10.2217/hep.15.5. Epub 2015 Apr 20.
6
Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinoma.预测肝细胞癌经皮射频消融术后的复发情况。
Hepat Oncol. 2014 Oct;1(4):395-408. doi: 10.2217/hep.14.22. Epub 2014 Dec 11.
7
Long-term survival after surveillance and treatment in patients with chronic viral hepatitis and hepatocellular carcinoma.慢性病毒性肝炎和肝细胞癌患者经监测与治疗后的长期生存情况。
Hepatol Commun. 2017 Jun 21;1(7):595-608. doi: 10.1002/hep4.1047. eCollection 2017 Sep.
8
Postoperative aspartate aminotransferase to lymphocyte ratio index change is an independent predictor of survival in patients with small hepatocellular carcinoma.术后天冬氨酸转氨酶与淋巴细胞比率指数变化是小肝细胞癌患者生存的独立预测指标。
Medicine (Baltimore). 2017 Nov;96(45):e8540. doi: 10.1097/MD.0000000000008540.
9
Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival.血小板与中性粒细胞比值变化可预测巴塞罗那临床肝癌分期A期肝细胞癌的生存率。
Medicine (Baltimore). 2017 Aug;96(33):e7821. doi: 10.1097/MD.0000000000007821.
10
Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.对比增强超声检查显示的不规则血管模式以及高血清豆凝集素反应性甲胎蛋白水平预示着早期肝细胞癌患者射频消融成功后预后不良。
Cancer Med. 2016 Nov;5(11):3111-3120. doi: 10.1002/cam4.932. Epub 2016 Oct 17.
经皮射频消融术与再次肝切除术治疗复发性肝细胞癌的回顾性研究
Ann Surg Oncol. 2008 Dec;15(12):3484-93. doi: 10.1245/s10434-008-0076-y. Epub 2008 Aug 5.
4
Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey.基于日本全国性调查的单发性肝细胞癌解剖性亚段切除术与非解剖性小肝切除术的疗效比较
Surgery. 2008 Apr;143(4):469-75. doi: 10.1016/j.surg.2007.12.003.
5
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?肝硬化患者极早期肝细胞癌射频消融术后的持续完全缓解率及并发症发生率:手术切除仍是首选治疗方法吗?
Hepatology. 2008 Jan;47(1):82-9. doi: 10.1002/hep.21933.
6
Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.针对孤立性肝细胞癌,宽切缘与窄切缘肝部分切除术的前瞻性随机试验。
Ann Surg. 2007 Jan;245(1):36-43. doi: 10.1097/01.sla.0000231758.07868.71.
7
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis.丙型肝炎病毒肝硬化患者肝切除术后应用α-干扰素预防肝细胞癌复发
Hepatology. 2006 Dec;44(6):1543-54. doi: 10.1002/hep.21415.
8
Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations.对所谓高危部位肝细胞癌的射频消融治疗。
Hepatology. 2006 May;43(5):1101-8. doi: 10.1002/hep.21164.
9
Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion.动脉内注射5-氟尿嘧啶与全身应用α-干扰素联合治疗伴门静脉侵犯的晚期肝细胞癌
Cancer. 2006 May 1;106(9):1990-7. doi: 10.1002/cncr.21832.
10
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma.一项比较经皮局部消融治疗与部分肝切除术治疗小肝细胞癌的前瞻性随机试验。
Ann Surg. 2006 Mar;243(3):321-8. doi: 10.1097/01.sla.0000201480.65519.b8.